Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. | J Clin Immunol | 2022 | 35748970 | PubTator, text mining | PubMed |
| The potential of pirtobrutinib in multiple B-cell malignancies. | Ther Adv Hematol | 2022 | 35747462 | PubTator, text mining | PubMed |
| Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas. | J Pers Med | 2022 | 35743749 | PubTator, text mining | PubMed |
| Breast Cancer Metastasis: Mechanisms and Therapeutic Implications. | Int J Mol Sci | 2022 | 35743249 | PubTator, text mining | PubMed |
| [Recurrent Darier-Ferrand dermatofibrosarcoma in the abdominal wall: the role of preoperative radiotherapy (case report)]. | Pan Afr Med J | 2022 | 35721637 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35713311 | PubTator, text mining | PubMed |
| Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension. | Front Pharmacol | 2022 | 35712711 | PubTator, text mining | PubMed |
| Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies. | Leuk Lymphoma | 2022 | 35704674 | PubTator, text mining | PubMed |
| Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study. | BMC Cancer | 2022 | 35698081 | PubTator, text mining | PubMed |
| Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors. | Oncoimmunology | 2022 | 35694193 | PubTator, text mining | PubMed |
| Statement on safety of cannabidiol as a novel food: data gaps and uncertainties. | EFSA J | 2022 | 35686177 | PubTator, text mining | PubMed |
| Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients. | Cancers (Basel) | 2022 | 35681706 | PubTator, text mining | PubMed |
| Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets. | Front Immunol | 2022 | 35669786 | PubTator, text mining | PubMed |
| SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases. | Front Oncol | 2022 | 35669422 | PubTator, text mining | PubMed |
| WASP family proteins: Molecular mechanisms and implications in human disease. | Eur J Cell Biol | 2022 | 35667337 | PubTator, text mining | PubMed |
| Acalabrutinib-Related Cardiac Toxicities in Patients with Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials. | J Immunother Precis Oncol | 2022 | 35664088 | PubTator, text mining | PubMed |
| Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy. | Oncoimmunology | 2022 | 35655707 | PubTator, text mining | PubMed |
| Zanubrutinib in lymphoproliferative disorders: a comprehensive review. | Ther Adv Hematol | 2022 | 35651781 | PubTator, text mining | PubMed |
| Identification of Two m6A Readers YTHDF1 and IGF2BP2 as Immune Biomarkers in Head and Neck Squamous Cell Carcinoma. | Front Genet | 2022 | 35646049 | PubTator, text mining | PubMed |
| The perception and response of T cells to a changing environment are based on the law of initial value. | Sci Signal | 2022 | 35639856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=31